Achmea Investment Management B.V. Edwards Lifesciences Corp Transaction History

Achmea Investment Management B.V.

$5.59 Billion
Q2 2024

A detailed history of Achmea Investment Management B.V. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Achmea Investment Management B.V. holds 50,390 shares of EW stock, worth $3.36 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

50,390

Previous 50,390 -0.0%

Holding current value

$3.36 Million

Previous $4.82 Million 3.34%

% of portfolio

0.08%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $852,770 - $1.07 Million	-13,819 Reduced 21.52%	50,390 $3.84 Million
Q3 2023 Nov 06, 2023	SELL	$69.28 - $93.38 $148,536 - $200,206	-2,144 Reduced 3.23%	64,209 $4.45 Million
Q2 2023 Jul 24, 2023	BUY	$81.41 - $94.33 $1.68 Million - $1.95 Million	20,682 Added 45.28%	66,353 $6.26 Million
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $1.02 Million - $1.16 Million	13,765 Added 43.14%	45,671 $3.78 Million
Q3 2022 Oct 27, 2022	SELL	$82.37 - $107.29 $854,424 - $1.11 Million	-10,373 Reduced 24.53%	31,906 $2.64 Million
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $952,278 - $1.41 Million	-11,009 Reduced 20.66%	42,279 $4.02 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $98,085 - $123,463	962 Added 1.84%	53,288 $6.27 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $173,595 - $213,269	-1,632 Reduced 3.02%	52,326 $6.78 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $140,060 - $167,062	1,361 Added 2.59%	53,958 $6.11 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $133,205 - $153,504	-1,693 Reduced 3.12%	52,597 $4.4 Million
Q4 2020 Feb 22, 2021	BUY	$71.69 - $91.23 $3,010 - $3,831	42 Added 0.08%	54,290 $4.95 Million
Q3 2020 Nov 02, 2020	BUY	$67.19 - $87.44 $3.64 Million - $4.74 Million	54,248 New	54,248 $4.33 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $1.39 Million - $2.14 Million	-26,463 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$71.7 - $82.09 $296,121 - $339,031	-4,130 Reduced 13.5%	26,463 $6.17 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $621,224 - $761,314	10,093 Added 49.23%	30,593 $6.73 Million
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $1.14 Million - $1.32 Million	20,500 New	20,500 $3.79 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $1.09 Million - $1.46 Million	-22,762 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $79,175 - $97,139	1,706 Added 8.1%	22,762 $3.49 Million
Q3 2018 Nov 06, 2018	BUY	$45.7 - $58.03 $424,507 - $539,040	9,289 Added 78.94%	21,056 $3.67 Million
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $85,083 - $99,184	2,518 Added 27.22%	11,767 $1.33 Million
Q2 2017 Aug 29, 2017	BUY	N/A	9,249	9,249 $1.09 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Edwards Lifesciences Corp Transaction History